Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2001-07-06
2009-02-10
Sitton, Jehanne S (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S024300
Reexamination Certificate
active
07488576
ABSTRACT:
The present invention provides methods for the diagnosis and treatment of psychiatric disorders. In particular, the present invention provides convergent functional genomics methods for the identification of candidate genes associated with psychiatric disorders such as mania and psychosis, as well as other multi-faceted diseases and syndromes.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4965188 (1990-10-01), Mullis
patent: WO 00/50436 (2000-08-01), None
Barrett et al; American Journal of Medical Genetics, vol. 96, pp. 494, abstract.
Barrett et al; Molecular Psychiatry, vol. 8, pp. 546-557, 2003.
Myles-Worsley et al, American Journal of Medical Genetics, vol. 88, pp. 544-550, 1999.
Compton et al; abstract from Gastroenteroloty, vol. 112, 1997.
Singleton et al; Neuroscience Letters, vol. 234, pp. 19-22; 1997.
Hacker et al; Gut, 1997, vol. 40, pp. 623-627.
Pennisi, Science, 1998; 281 (5384):1787-1789.
Niculescu et al; Physiol. Genomics, vol. 4, pp. 83-91, 2000.
Calabrese et al; Genomics, vol. 23, pp. 286-288, 1994.
Blast analysis of chromosome 22 sequence from Sanger center (Jan. 12, 1999) with SEQ ID No: 1.
Willner “Dopaminergic Mechanisms in Depression and Mania,” inPsychopharmacology: The Fourth Generation of Progress, Bloom and Kupfer (eds.), Raven Press, NY, 1995, Chapter 80, p. 921.
Berrettini (2000) “Susceptibility Loci for Bipolar Disorder: Overlap with Inherited Vulnerability to Schizophrenia,” Biol. Psychiatr. 47:245.
Kelsoe (1999) “Recent Progress in the Search for Genes for Bipolar Disorder,” Curr. Psychiatr. Rep. 1:135.
Lipshutz et al. (1999) “High density synthetic oligonucleotide arrays,” Nat. Genet. 21:20.
Heimer and Alheid (1991) “Piecing Together the Puzzle of Basal Forebrain Anatomy,” Adv. Exp. Med. Biol. 1:295.
Lander and Kruglyak (1995) “Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results,” Nat. Genet. 11:241.
Lachman et al. (1996) “Linkage Studies Suggest a Possible Locus of Bipolar Disorder Near the Velo-Cardio-Facial Syndrome Region on Chromosome 22,” Am. J. Med. Genet. 74:121.
Kelsoe et al. (1998) “A Genome Survey of Bipolar Disorder Indicates a Susceptibility Locus on Chromosome 22,” Am. J. Med. Genet. 81:461, Abstract.
Edenberg et al. (1997) “Initial Genomic Scan of the NIMH Genetics Initiative Bipolar Pedigrees: Chromosomes 3, 5, 15, 16, 17, and 22,” Am. J. Med. Genet. 74:238.
Detera-Wadleigh et al. (1999) “A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2,” Proc. Natl. Acad. Sci. USA 96:5604.
Myles-Worsley et al. (1999) “Linkage of a Composite Inhibitory Phenotype to a Chromosome 22q Locus in Eight Utah Families,” Am. J. Med. Gente. 88:544.
Pitcher et al. (1998) “G Protein-Coupled Receptor Kinases,” Ann. Rev. Biochem. 67:653.
Tiberi et al. (1996) “Differential Regulation of Dopamine DIA Receptor Responsiveness by Various G Protein-coupled Receptor Kinases,” J. Biol. Chem. 271:3771.
Arriza et al. (1992) “The G-Protein-coupled Receptor Kinases βARK1 and βARK2 Are Widely Distributed at Synapses in Rat Brain,” J. Neurosci. 12:4045.
Garcia-Sevilla et al. (1999) “Up-Regulation of Immunolabled α2A-Adrenoceptors, G1Coupling Proteins, and Regulatory Receptor Kinases in the Prefrontal Cortex of Depressed Suicides,” J. Neurochem. 72:282.
Ripperger et al., (2000) “Clock, an essential pacemaker component, controls expression of the circadian transcription factor DPB,” Genes Dev. 14:679.
Yan et al. (2000) “Distribution and Circadian Expression of dbp is SCN and Extra-SCN Areas in the Mouse Brain,” J. Neurosci. Res. 59:291.
Franken et al. (2000) “The Transcription Factor DBP Affects Circadian Sleep Consolidation and Rhythmic EEG Activity,” J. Neurosci. 20:617.
Andretic et al. (1999) “Requirement of Circadian Genes for Cocaine Sensitization inDrosphila, ” Science 285:1066.
Kripke et al. (1978) “Circadian Rhythm Disorders in Manic-Depressives,” Biol. Psychiatr. 13:335.
Bunney and Bunney (2000) “Molecular Clock Genes in man and Lower Animals: Possible Implications for Circadian Abnormalities in Depression,” Neuropsychopharmacol. 22:335
Morissette et al. (1999) “Genome-Wide Search for Linkage of Bipolar Affective Disorders in a Very Large Pedigree Derived from a Homogeneous Population in Quebec Points to a Locus of Major Effect on Chromosome 12q23-q24,” Am. J. Med. Genet. 88:567.
Schechter et al. (1994) “Localization of the Squalene Synthase Gene (FDFTI) to Human Chromosome 8p22-p23.1,” Genomics 20:116.
Engelberg (1992) “Low serum cholesterol and suicide,”Lancet 339:727.
Kaplan et al. (1997) “Assessing the Observed Relationship between Low Cholesterol and Violence-related Mortality,” Ann. NY Acad. Sci. 836:57.
Tozawa et al. (1999) “Embryonic Lethality and Defective Neural Tube Closure in Mice Lacking Squalene Synthase,” J. Biol. Chem. 274:30843.
Michikawa and Yanagisawa (1999) “Apolipoprotein E4 isoform-specific actions on neuronal cells in culture,” Mech. Ageing Dev. 107:223.
Wetterberg et al. (1998) “Search for Schizophrenia Loci in a Swedish Geographic Isolate,” Am. J. Med. Genet. 81:470, Abstract.
Kaufmann et al. (1998) “NIMH Genetics Initiative Millennium Schizophrenia Consortium,” Linkage Analysis of African-American Pedigress, Am. J. Med. Genet. 81:282.
Jo et al. (1999) “Characterization of MALS/Velis-1, -2, and -3: a Family of Mammalian LIN-7 Homologs Enriched at Brain Synapses in Association with the Postsynaptic Density-95/NMDA Receptor Postsynaptic Complex,” J. Neurosci. 19:4189.
Butz et al. (1998) “A Tripartite Protein Complex with the Potential to Couple Synaptic Vesicle Exocytosis to Cell Adhesion in Brain,” Cell 94:773.
Dawson et al. (1995) “Linkage Studied on Bipolar Disorder in the Region of the Darier's Disease Gene on Chromosome 12q23-24.1,” Am. J. Med. Genet. 60:94.
Ewald et al. (1995) “A possible locus for manic depressive illness on chromosome 16p13,” Psychiatr. Genet. 5:71.
Hwang and Choi (1995) “Induction of Gene Expression of the Catecholamine-Synthesizing Enzymes by Insulin-Like Growth Factor-1,” J. Neurochem. 65:1988.
Knusel et al. (1991) “Trophic Actions of IGF-1, IGF-II and Insulin on Cholinergic and Dopaminergic Brain Neurons,” Adv. Exp. Med. Biol. 293:351.
Beck et al. (1995) “Igfl Gene Disruption Results in Reduced Brain Size, CNS Hypomyelination, and Loss of Hippocampal Granule and Striatal Parvalbumin-Containing Neurons,” Neuron 14:717.
Schmidt and Schibler (1995) “Cell Size Regulation, a Mechanism That Controls Cellular RNA Accumulation: Consequences on Regulation of the Ubiquitous Transcription Factors Oct. 1 and NF-Y, and the Liver-enriched Transcription Factor DBP,” J. Cell Biol. 128:467.
Bina et al. (2000) “Syndromes Associated withHomo sapiensPol II Regulatory Genes,” Prog. Nucl. Acid Res. Mol. Biol. 64:171.
Kandil et al. (1996) “The human gene encoding the heavy chain of the major histocompatibility complex class I-like Fc receptor (FCGRT) maps to 19q13.3,” Cytogenet. Cell Genet. 73:97.
Flores et al. (1998) “Long-Lasting Induction of Astrocytic Basic Fibroblast Growth Factor by Repeated Injections of Amphetamine: Blockade by Concurrent Treatment with a Glutamate Antagonist,” J. Neurosci. 18:9547.
Rabinovsky et al. (1995) “Regulation of Tyrosine Hydroxylase Gene Expression in IMR-32 Neuroblastoma Cells by Basic Fibroblast Growth Factor and Ciliary Neurotrophic Factor,” J. Neurochem. 64:2404.
Blouin et al. (1998) “Schizophrenia susceptibility loci on chro
Barrett Thomas B.
Kelsoe, Jr. John R.
Niculescu, III Alexander B.
Medlen & Carroll LLP
Sitton Jehanne S
The Regents of the University of California
LandOfFree
Methods for diagnosis and treatment of psychiatric disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for diagnosis and treatment of psychiatric disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosis and treatment of psychiatric disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4066956